Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Microbiome metabolites and host responses

Sep. 10, 2018

Beta1-integrin promotes endothelial barrier disruption: a new target to prevent vascular leakage

Sep. 7, 2018

Shire Human Genetic Therapies patents TGF-beta inhibitors

Aug. 28, 2018

Galecto Biotech compound is an orally available drug for fibrosis and cancer

Aug. 28, 2018

Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor

Aug. 28, 2018

Cathepsin S inhibitors discovered at Astellas

Aug. 23, 2018

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Aug. 22, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery

Aug. 13, 2018

Uncovering the function of Cep57 in mosaic-variegated aneuploidy syndrome

Aug. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...